Sector: Health Care.Industry: Pharmaceuticals
Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, to create treatments for people with cancer. Its oncology pipeline includes NT219 and CM24.
Earnings
see more| Q2 2021 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2021-07-29 | ||||||
| REV | |||||||
| Q1 2021 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2021-05-21 | ||||||
| REV | |||||||
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| PPBT | Purple Biotech | 1.53% |
Purple Biotech Company Questions & Answers
Q
How do I buy Purple Biotech (PPBT) stock?
A
You can purchase shares of Purple Biotech (NASDAQ: PPBT) through any online brokerage.
Q
Who are Purple Biotech's (PPBT) main competitors?
A
Other companies in Purple Biotech’s space includes: Reata Pharmaceuticals (NASDAQ:RETA), Johnson & Johnson (NYSE:JNJ) and Merck & Co (NYSE:MRK).
Q
What is the target price for Purple Biotech?
A
There is no analysis for Purple Biotech
Q
How much is Purple Biotech (PPBT) stock ?
A
The stock price for Purple Biotech (NASDAQ: PPBT) is $3.97 last updated Fri May 07 2021 20:00:02 GMT+0000 (Coordinated Universal Time).
Q
When is the next Purple Biotech (PPBT) dividend?
A
There are no upcoming dividends for Purple Biotech.
Q
When is Purple Biotech (NASDAQ:PPBT) reporting earnings?
A
Purple Biotech’s Q2 earnings are confirmed after-market from now on July 29, 2021.
Q
When is the upcoming split for PPBT?
A
There is no upcoming split for Purple Biotech.